01 · Process stage
PlannedMaterial & component preparation
Define active ingredient handling, formulation status and the requirements for product-contact equipment.
Capabilities · Ophthalmic, inhaled & other delivery forms
Ophthalmic preparations
A proposed service scope for ophthalmic presentations, connecting formulation preparation, sterilisation approaches, container handling and contamination controls for eye drops or ointments.
PlannedCatalogue scope
Service statusPlanned
Planned.
Technical boundaries and readiness need confirmation before an activity could be presented as available.
Basis · Catalogue scope
- Status
- PlannedNo available service asserted
- Source-plan relationship
- Catalogue scopeProposed catalogue expansion
- Readiness
- Not establishedProduct and process evidence needed
- Facility roadmap
- First commercial batch target Q1 2028 · indicativeNot a service date
01 · Proposed service scope
Start with the product and its container.
Ophthalmic preparation is presented as a planned service domain. The exact product, container presentation, sterility requirement and technical manufacturing route would define its specific technical scope.
The initial Boten formulation-and-filling plan identifies distinct injectable presentations. This proposed ophthalmic service domain lies outside that initial plan, and any such addition would require separate scope confirmation.
Terminal sterilisation and aseptic processing represent distinct technical subjects for ophthalmic liquids. Inclusion in a common catalogue does not establish that one route is appropriate for a particular formulation.
Catalogue boundary
A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.
02 · Presentation families
Match the route to the format.
| Format | Planning note | Basis | Status |
|---|---|---|---|
| Liquid eye dropsTopical solutions & washes | Proposed presentation format for liquid preparations; requires distinct contamination controls. | Catalogue scope | Planned |
| Ophthalmic ointmentsCreams & ointments | Semi-solid formulation intended for ocular administration; subject to separate qualification. | Catalogue scope | Planned |
| Ophthalmic gelsGels & lotions | Viscous liquid or semi-solid presentation; would require specific handling equipment. | Catalogue scope | Planned |
03 · Process scope for discussion
Make the sequence and its evidence visible.
02 · Process stage
PlannedCompounding & filtration assessment
Consider compounding steps and the suitability of any sterilising filtration for the specific liquid.
03 · Process stage
PlannedSterilisation route definition
Establish the appropriate method for achieving product sterility based on the formulation properties.
04 · Process stage
PlannedContainer handling & filling
Define component preparation, liquid dispensing controls and the required processing environment for the presentation.
05 · Process stage
PlannedClosure & visual inspection
Consider tip insertion, capping steps and the necessary inspection criteria for the sealed unit.
06 · Process stage
PlannedTesting & review interfaces
Connect the manufacturing record, analytical results and accountable review decisions for the completed batch.
Illustrative sequence
This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.
04 · Supporting services
No service stands alone.
01PlannedCatalogue scope
Terminal sterilisation
Suitability of the product, container and proposed sterilisation process.
Explore proposed scope02PlannedCatalogue scope
Creams & ointments
Mixing, homogenisation, transfer and tube or container filling.
Explore proposed scope03PlannedCatalogue scope
Container-closure integrity testing
Presentation-specific integrity questions and the supporting method.
Explore proposed scope05 · Readiness questions
A service claim needs a defined evidence base.
- Product & presentation
- Exact liquid or semi-solid formulation and the intended container-closure system.
- Facility & systems
- Appropriate installed compounding and filling systems with an approved scope.
- Process evidence
- Defined manufacturing parameters, appropriate sterilisation evidence and required contamination controls.
- Quality responsibilities
- Controlled processing records, analytical scope and accountable review rights.
- Regulatory context
- Applicable product and facility permissions for the intended ophthalmic activity.
- Technical agreement
- Defined responsibilities, technical boundaries and disclosure rules for any engagement.
06 · Practical questions
Before a technical discussion.
Is this service currently available?
No. The service is Planned. This page is a scope proposal and does not establish an operating ophthalmic preparation service.
Are ophthalmic presentations part of the initial plan?
No. The initial Boten plan focuses on specific injectable dosage forms. Ophthalmic drops and ointments represent proposed additions that would require distinct scope confirmation.
What information helps define the question?
Identify the proposed formulation, container presentation, development stage, destination and the specific technical question. Confidential data should only be shared through an agreed route.
Is there a service launch quarter?
No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual proposed domain to a start date.
Does a technical discussion establish supply?
No. Feasibility, scope, permissions, equipment evidence and any formal agreement would need to be established before a service commitment.
Professional enquiries
Discuss a defined question.
Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.